Picture2.jpg
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
July 17, 2024 07:25 ET | ASLAN PHARMACEUTICALS LIMITED
Following a thorough review of all strategic alternatives, ASLAN Pharmaceuticals Pte Ltd, the sole operating subsidiary of ASLAN Pharmaceuticals, has filed for voluntary liquidation Quantuma...
Alterity.png
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
July 17, 2024 07:25 ET | ALTERITY THERAPEUTICS LIMITED
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated...
22157.jpg
North America Cloud-Based Systems and Remote Systems Electronic Health Records (EHR) Market Outlook 2024-2033 Featuring Cerner, Constellation Software, Concentrix, Veradigm, & Leidos
July 17, 2024 07:23 ET | Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "North America Electronic Health Records Market Outlook to 2033 - Cloud-Based Systems and Remote Systems" report has been added to ...
Form 8.3 - Equals Group PLC
July 17, 2024 07:21 ET | Downing LLP
Downing LLP LEI: 213800G3X76VBG9SB504 17 July 2024  Form 8.3 re. Equals Group Plc  PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
Unknown.jpg
Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board
July 17, 2024 07:15 ET | Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...
Pandora_Logo_Black_RGB_Screens.png
MAJOR SHAREHOLDER ANNOUNCEMENT
July 17, 2024 07:13 ET | Pandora A/S
In accordance with Section 30 of the Capital Markets Act, Pandora A/S hereby announces that BlackRock, Inc. has notified the company regarding changes in their holdings. Initially, BlackRock...
Final Logo-01.png
Virtual Hospitals Market Size to Reach USD 116.4 Million by 2034, Growing at 26.9% CAGR: Prophecy Market Insights
July 17, 2024 07:08 ET | PMI
Covina, July 17, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights Virtual Hospitals Market Size is expected to reach at USD 13.3 million in 2024 and is projected to grow at a CAGR of...
scilogo.jpg
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
July 17, 2024 07:07 ET | SciSparc Ltd
SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...
OXB.jpg
Oxford Biomedica announces CFO transition
July 17, 2024 07:06 ET | Oxford BioMedica plc
Oxford Biomedica announces Chief Financial Officer transition - Lucinda Crabtree to join as Chief Financial Officer - Oxford, UK – 17 July 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”,...
UNCY Logo.jpg
Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
July 17, 2024 07:03 ET | Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...